RyR2-targeting therapy prevents left ventricular remodeling and ventricular tachycardia in post-infarction heart failure
Journal of Molecular and Cellular Cardiology(2023)
摘要
Pharmacological or genetic stabilization of RyR2 tetrameric structure improves survival after MI by suppressing LV remodeling and proarrhythmia.
更多查看译文
关键词
Calmodulin,Dantrolene,Heart failure,Myocardial infarction,Ryanodine receptor,Ventricular tachycardia
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要